This inventor holds 1 USPTO granted patent. Top assignee: C. R. Bard, Inc.. Active years: 1994.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1994
Title: Michael G Dumont: Innovator in Angioplasty Technology
Introduction
Michael G Dumont is a notable inventor based in Stratham, NH (US). He has made significant contributions to the field of medical technology, particularly in the development of angioplasty systems. His innovative approach has led to advancements that enhance the identification and treatment of atherosclerotic plaque in blood vessels.
Latest Patents
Dumont holds a patent for an angioplasty system that includes means for the identification of atherosclerotic plaque. This system utilizes fluorescence analysis to identify noncalcified plaque and calcium photoemission analysis for calcified plaque. The technology distinguishes between calcium photoemission and potential defects in the optical fibers used for laser energy delivery. The system is designed to improve the precision of laser ablation procedures, ensuring better outcomes for patients.
Career Highlights
Throughout his career, Michael G Dumont has been associated with C. R. Bard, Inc., a company known for its innovative medical devices. His work has focused on enhancing the efficacy of angioplasty procedures, contributing to improved patient care and outcomes. With a patent portfolio that includes 1 patent, Dumont has established himself as a key figure in medical device innovation.
Collaborations
Dumont has collaborated with notable colleagues, including Glenn S Baker and Michael Madden. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of medical technology.
Conclusion
Michael G Dumont's contributions to angioplasty technology exemplify the impact of innovation in healthcare. His work continues to influence the development of advanced medical devices that improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
